RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)
Turkey
· Delayed Price · Currency is TRY 3.810
-0.130 (-3.30%)
At close: Mar 6, 2026
IST:RTALB Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 239.56 | 158.59 | 138.51 | 191.3 | 384.34 | Upgrade
|
| Revenue Growth (YoY) | 51.06% | 14.50% | -27.59% | -50.23% | 66.79% | Upgrade
|
| Cost of Revenue | 156.68 | 117.61 | 112.71 | 126.73 | 228.46 | Upgrade
|
| Gross Profit | 82.89 | 40.98 | 25.8 | 64.57 | 155.88 | Upgrade
|
| Selling, General & Admin | 63.26 | 37.92 | 44.92 | 54.89 | 40.54 | Upgrade
|
| Research & Development | 37.07 | 22.19 | 21.46 | 14.23 | 16.6 | Upgrade
|
| Other Operating Expenses | 1.68 | 23.08 | 9.28 | 11.05 | 3.95 | Upgrade
|
| Operating Expenses | 102.01 | 83.19 | 75.66 | 80.17 | 61.09 | Upgrade
|
| Operating Income | -19.13 | -42.2 | -49.86 | -15.6 | 94.79 | Upgrade
|
| Interest Expense | -68.28 | -78 | -29.44 | -32.18 | -19.73 | Upgrade
|
| Interest & Investment Income | 213.48 | 73.99 | 126.42 | 76.02 | 19.58 | Upgrade
|
| Earnings From Equity Investments | 1,105 | 119.52 | -61.23 | 280.78 | 46.86 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 7.37 | 46.38 | 79.98 | 6.88 | Upgrade
|
| Other Non Operating Income (Expenses) | 20.5 | -81.94 | -133.37 | -213.34 | -0.18 | Upgrade
|
| EBT Excluding Unusual Items | 1,251 | -1.26 | -101.1 | 175.66 | 148.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.91 | -50.4 | -3.66 | -2.79 | -0.85 | Upgrade
|
| Pretax Income | 1,249 | -51.66 | -104.76 | 172.87 | 147.36 | Upgrade
|
| Income Tax Expense | 368.16 | -103.9 | -1.6 | 36.55 | 20.06 | Upgrade
|
| Earnings From Continuing Operations | 881.18 | 52.23 | -103.16 | 136.32 | 127.3 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -155.95 | -12.83 | Upgrade
|
| Net Income | 881.18 | 52.23 | -103.16 | -19.62 | 114.47 | Upgrade
|
| Net Income to Common | 881.18 | 52.23 | -103.16 | -19.62 | 114.47 | Upgrade
|
| Net Income Growth | 1586.96% | - | - | - | 87.87% | Upgrade
|
| Shares Outstanding (Basic) | - | 500 | 500 | 500 | 500 | Upgrade
|
| Shares Outstanding (Diluted) | - | 500 | 500 | 500 | 500 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 4.81% | Upgrade
|
| EPS (Basic) | - | 0.10 | -0.21 | -0.04 | 0.23 | Upgrade
|
| EPS (Diluted) | - | 0.10 | -0.21 | -0.04 | 0.23 | Upgrade
|
| EPS Growth | - | - | - | - | 79.25% | Upgrade
|
| Free Cash Flow | 120.97 | -180.9 | 23.93 | -0.77 | 47.35 | Upgrade
|
| Free Cash Flow Per Share | - | -0.36 | 0.05 | -0.00 | 0.10 | Upgrade
|
| Gross Margin | 34.60% | 25.84% | 18.63% | 33.76% | 40.56% | Upgrade
|
| Operating Margin | -7.98% | -26.61% | -36.00% | -8.15% | 24.66% | Upgrade
|
| Profit Margin | 367.83% | 32.94% | -74.48% | -10.26% | 29.78% | Upgrade
|
| Free Cash Flow Margin | 50.50% | -114.07% | 17.28% | -0.40% | 12.32% | Upgrade
|
| EBITDA | 12.57 | -25.43 | -33.85 | 6.66 | 98.74 | Upgrade
|
| EBITDA Margin | 5.25% | -16.04% | -24.44% | 3.48% | 25.69% | Upgrade
|
| D&A For EBITDA | 31.7 | 16.77 | 16.01 | 22.26 | 3.95 | Upgrade
|
| EBIT | -19.13 | -42.2 | -49.86 | -15.6 | 94.79 | Upgrade
|
| EBIT Margin | -7.98% | -26.61% | -36.00% | -8.15% | 24.66% | Upgrade
|
| Effective Tax Rate | 29.47% | - | - | 21.14% | 13.61% | Upgrade
|
| Advertising Expenses | - | - | 0.02 | 0.02 | 1.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.